A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)
Clinical trial NCT00106535 · COMPLETED
Trial details
- NCT number
- NCT00106535
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2007-05-01
- Enrollment
- 1196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.